Actavis PLC news

   Watch this stock
Showing stories 1 - 10 of about 18   

Articles published

After Libor � the search for a new benchmark
Back in the 1980s, traders and bankers who specialised in the new and exotic fields of loan syndication and forward rate agreements found themselves in desperate need of a benchmark against which to price their deals.
Related articles »  
Shire changes NASDAQ ticker symbol to SHPG starting Wednesday
With the opening of trading on Wednesday, Shire plc's American Depository Shares will change ticker symbols on the NASDAQ market, from SHPGY to SHPG.
Related articles »  
Analysis: Small generic drug firms need niches to survive looming price war
U.S. companies such as Impax Laboratories Inc and Hi-Tech Pharmacal Co Inc and Europe's Stada, Hikma Pharmaceuticals Plc, Krka and Pharmstandard are expected to feel the pressure of the changing market dynamics, industry analysts said. Recent deals ...
Related articles »  
Basic patent and SPC � what do they actually cover?
Novartis AG had requested injunctive relief against Actavis Deutschland GmbH & Co. KG, enjoining them from distributing a generic combination medicament containing the active ingredients Valsartan and Hydrochlorothiazide (HCTZ1) for the treatment of ...
Related articles »  
Watson and Actavis Receive FTC Second Request
The effect of the second request is to extend the waiting period imposed by the HSR Act until 30 days after Watson and Actavis have substantially complied with the request, unless that period is extended voluntarily by the parties or terminated sooner ...
Related articles »  
JPMorgan Analyst Makes Key Research Calls in Auto Sector
Overweight ratings were seen in the following stocks: Autoliv Inc. (NYSE: ALV); BorgWarner Inc. (NYSE: BWA); Delphi Automotive PLC (NYSE: DLPH); Gentex Corp. (NASDAQ: GNTX); Harman International Industries (NYSE: HAR); Tenneco Inc. (NYSE: TEN); ...
Related articles »  
New tools for arguing against the use of hindsight and common sense in ...
In a victory for patent applicants and owners, a recent decision by the Federal Circuit re-emphasized the importance of the Graham factors to avoid the ever-present risk of using hindsight when making an obviousness determination, and questioned the ...
Actavis Receives Tentative Approval of Generic Intuniv� (Guanfacine Extended ...
MORRISTOWN, N.J., July 5, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, announced that on June 29, 2012 it received tentative approval from the US Food and Drug Administration for Guanfacine ...
Related articles »  
Deals of the Week Doubles Down on Neuroscience
Hit me! While many Big Pharmas have shied away from central nervous system drugs lately, at least one is placing bets on early-stage scientific advancements in neuroscience.
Merck KGaA's Cancer Drug Erbitux Fails In Gastric Cancer Study
Merck KGaA (MKGAY.PK) said its cancer drug Erbitux failed to meet primary goal of progression-free survival in a late-stage trial in patients with advanced gastric cancer.
Related articles »